Negen
Earliest possible personalised chronic disease prevention utilising genomics.
Launch date
Employees
Company register number 2677156-7
Helsinki Uusimaa (HQ)
Financials
Estimates*
| EUR | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Revenues | <1m | <1m | <1m | <1m | <1m | (<1m) |
| % growth | - | 917 % | 97 % | (65 %) | 74 % | (101 %) |
| Profit | (<1m) | (<1m) | (<1m) | (<1m) | (<1m) | (<1m) |
| % profit margin | (867 %) | (552 %) | (325 %) | (293 %) | (70 %) | 11200 % |
| R&D budget | <1m | <1m | <1m | <1m | - | - |
| R&D % of revenue | 1667 % | 148 % | 83 % | 238 % | - | - |
Source: Dealroom estimates
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
* | N/A | Acquisition | |
| Total Funding | - | ||
Related Content
Recent News about Negen
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.